series-b
Stage
4
Investors
About
Ethris develops mRNA-based therapeutics and vaccines using proprietary RNA and lipid nanoparticle delivery technologies, focusing on treating pulmonary diseases including asthma and rare lung disorders.
Explore Ethris's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.